UPC (Universe Pharmaceuticals) Cash Flow from Others: $0.37 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

UPC Universe Pharmaceuticals Inc UPC
52 GF Score
Price $4.46
GF Value $2.74
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Universe Pharmaceuticals Cash Flow from Others?

Universe Pharmaceuticals UPC -6.89% 52 Cash Flow from Others is $0.37 Mil as of Mar. 2026. GuruFocus rates UPC with a GF Score™ of 52/100 and a GF Value™ of $2.74 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Universe Pharmaceuticals's cash flow from others for the six months ended in Mar. 2026 was $0.00 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Mar. 2026 was $0.37 Mil.

Universe Pharmaceuticals Cash Flow from Others Related Terms

Universe Pharmaceuticals Cash Flow from Others Historical Data

* Premium members only.

The historical data trend for Universe Pharmaceuticals's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Universe Pharmaceuticals Cash Flow from Others Chart

Universe Pharmaceuticals Annual Data
Trend Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Cash Flow from Others
Get a 7-Day Free Trial -0.23 0.44 -0.05 0.19 0.37

Universe Pharmaceuticals Semi-Annual Data
Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Cash Flow from Others Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -0.30 -10.23 -0.00 0.37 0.00
UPC
52GF Score
Universe Pharmaceuticals Inc UPC
Cash Flow from Others is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Universe Pharmaceuticals Cash Flow from Others Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.37 Mil.

Frequently Asked Questions Learn more about Cash Flow from Others →
What does a Cash Flow from Others of $0.37 Mil mean?
Universe Pharmaceuticals (UPC) has a Cash Flow from Others of $0.37 Mil as of Mar. 2026. Cash Flow from Others is the amount of cash earned or paid from other, nonstandard operations. View historical data for Universe Pharmaceuticals and its competitors.
Is Universe Pharmaceuticals' Cash Flow from Others too high?
Universe Pharmaceuticals' current Cash Flow from Others is $0.37 Mil. Overall, Universe Pharmaceuticals has a GF Score™ of 52/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Universe Pharmaceuticals' Cash Flow from Others compare to CTTH and PRFX?
Universe Pharmaceuticals' Cash Flow from Others of $0.37 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Others for a Drug Manufacturers company?
A good Cash Flow from Others depends on the Drug Manufacturers industry context. However, Cash Flow from Others should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Others mean?
A high Cash Flow from Others can signal that a stock is expensive relative to its fundamentals. Cash Flow from Others is the amount of cash earned or paid from other, nonstandard operations. View historical data for Universe Pharmaceuticals and its competitors. Universe Pharmaceuticals's current Cash Flow from Others is $0.37 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Universe Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Universe Pharmaceuticals (UPC) is currently considered Significantly Overvalued. The stock's GF Value™ is $2.74, compared to a current price of $4.46 — trading 62.8% above its estimated fair value. The current Cash Flow from Others is $0.37 Mil. Universe Pharmaceuticals' overall GF Score™ is 52/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Others calculated?
Cash Flow from Others is calculated from a company's financial statements. For Universe Pharmaceuticals (UPC), the current Cash Flow from Others is $0.37 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Universe Pharmaceuticals (UPC) Overvalued in 2026?

Based on GuruFocus' analysis, Universe Pharmaceuticals stock appears to be overvalued. The current stock price of $4.46 is trading 62.8% above its estimated GF Value™ of $2.74. GuruFocus considers Universe Pharmaceuticals to be Significantly Overvalued.

Key valuation signals for UPC:

  • Cash Flow from Others: $0.37 Mil
  • GF Value™: $2.74 vs. price of $4.46 (62.8% above fair value)
  • GF Score™: 52/100 with 7 warning signs

No single metric tells the full story. See the UPC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Universe Pharmaceuticals Business Description

Address 265 Jingjiu Avenue, Jinggangshan Economic & Technological Development Zone, Jiangxi, Ji’an, CHN, 343100
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.
52GF Score

Get the complete analysis for UPC

Cash Flow from Others is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.46
Price
$2.74
GF Value